Invited commentary. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting.
Pandit
Lekha
L
Department of Neurology, KS Hegde Medical Academy, Mangalore, India. Panditmng@gmail.com
D000700:Analgesics / Q000627:therapeutic use*; D006801:Humans; D008942:Mitoxantrone / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*
D000700:Analgesics; D008942:Mitoxantrone